Cardinal Health Reports Strong First-Quarter Results For Fiscal 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Cardinal Health Reports Strong First-Quarter Results For Fiscal 2016
November 4, 2015 3:03 PM EST
Leerink Partners reiterated an Outperform rating on Cardinal Health (NYSE: CAH), and raised the price target to $105.00 (from $100.00), following the company's 1Q16 earnings conference call. The strong 49bp increase in pharmaceutical segment operating margin (to 2.61%) was driven by generic strength. F2016 pharmaceutical segment revenue is now expected to be in the... More
November 3, 2015 8:36 AM EST
UBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following 1Q16 earnings call. On CAH's F1Q16 earnings call, the company provided some fresh input on the outlook for both brand and generic pricing. Regarding brand drug inflation, the rate in F1Q16 was slightly higher than the prior... More
November 2, 2015 7:47 AM EST
Cardinal Health (NYSE: CAH) reported Q1 EPS of $1.38, $0.28 better than the analyst estimate of $1.10. Revenue for the quarter came in at $28.1 billion versus the consensus estimate of $27.18 billion.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
...
More
